BioSpace News Archive

Drug Development

Forendo Pharma Successfully Completes Phase 1a Clinical Trial of FOR-6219 for the Treatment of Endometriosis

Forendo Pharma today announces that it has successfully completed Phase 1a study of FOR-6219, an HSD17B1 inhibitor for the treatment of endometriosis.

March 8, 2019
·
2 min read
Bio NC

Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision® Liquid Biopsy Test

Large, real-world, prospective study shows Inivata’s liquid biopsy test is able to provide molecular profile when tissue is unavailable and guide personalized treatment

March 8, 2019
·
3 min read
Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase designed specifically to meet the needs of diagnostic kit developers.

March 8, 2019
·
2 min read
Lystek’s Commercial Scale, Containerized Mobile THP Units Ready to Serve the Needs of Biosolids Processing Sector

Attention: Environmental, agricultural, municipal, recycling & waste management reporters/editors

March 8, 2019
·
3 min read
Deals

Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019

Auris Medical Holding AG announced that it will provide a business update and report its financial results for the fourth quarter and full year 2018 on Thursday, March 14, 2019.

March 8, 2019
·
1 min read
BioCapital

SCRS Announces the Launch of New and Improved Website

The Society for Clinical Research Sites is pleased to announce the launch of our new website at MySCRS.org.

March 8, 2019
·
1 min read
Business

Oxurion NV Business Update – FY 2018

Significant Progress with Novel Diabetic Eye Disease Portfolio

March 8, 2019
·
17 min read
Policy

FDA Advisory Panel Gives Mixed Review to Sanofi’s Dengue Vaccine

Sanofi has been hoping to secure approval from the U.S. Food and Drug Administration for its dengue vaccine, but a mixed review from a panel of experts could sink the chances of a green light for the medication.

March 8, 2019
·
2 min read
·
Alex Keown
FDA

FDA Action Alert: Regeneron, Celgene and Aerie

The next couple of weeks look to be busy for the FDA, with a string of target action dates scheduled. This week marks three scheduled approvals, two for extra indications for already-approved biologics, and the third for a combination treatment for glaucoma. Here’s a look.

March 8, 2019
·
3 min read
·
Mark Terry
Policy

BIO Calls for Innovation in Addressing the Opioid Crisis

As drugmakers continue to develop an understanding of what pain is to the human body, it helps drive the development of innovative manners to treat it that transcend addictive options such as opioids.

March 8, 2019
·
3 min read
·
Alex Keown